Core Cap Advisors, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Core Cap Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $5.46 $82 - $4,095	750 New	750 $0
Q2 2022 Aug 11, 2022	BUY	$0.21 - $0.53 $157 - $397	750 New	750 $0
Q1 2022 Apr 29, 2022	SELL	$0.32 - $0.67 $240 - $502	-750 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$0.6 - $1.11 $450 - $832	750 New	750 $1,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Core Cap Advisors, LLC with notifications on news.